cGxP.wire https://validator.w3.org/feed/docs/rss2.html Medtronic Reports Positive Cardiac Ablation Registry Results Otsuka Reports Final Phase 3 VOYXACT Results in IgA Nephropathy Fresenius Launches multiFiltratePRO for Critical Kidney Care Genialis Demonstrates Biology-First AI in Cancer Research Alnylam Reports Positive Phase 1b Data for Brezosiran in Huntington’s Disease Summit Therapeutics and Lunit Partner on AI Cancer Research QIAGEN and EQT Agree on €10.8B All-Cash Takeover Deal Genmab Reports Positive Phase 3 Results for Rina-S in Ovarian Cancer Johnson & Johnson Advances Solid Tumor Pipeline at ESMO 2026 Elucid Wins FDA Clearance for FFR-IQ Heart Imaging Software Tango Reports 82% Response Rate in Pancreatic Cancer Trial Sony Launches 1mm Image Sensor for Medical Endoscopes M42 and Inocras Partner on Cancer Recurrence Detection in UAE Breakthrough T1D and Eledon Expand Islet Transplant Trial Zymeworks Licenses DLL3 T-Cell Engager ZW209 to Roche Santhera Pharmaceuticals and Nxera Pharma Submit AGAMREE® Marketing Application in South Korea Kibow KT-301 Shows Promise in Stage 4 Kidney Disease Fresenius Backs HHS National Kidney Care Plan Enterome Reports EO4010 Immune Response and Survival Data Evaxion Reports Three-Year EVX-01 Vaccine Data in Melanoma Spine Innovation Performs First LOGIC Ti Implant Surgery Nuravax Wins FDA Fast Track for Alzheimer’s Vaccine ORIC Pharmaceuticals Reports Promising Enozertinib Data in NSCLC AstraZeneca Launches ZEGFROVY in the US for EGFR-Mutated NSCLC Xylyx Bio Wins FDA Orphan Status for Inspirex Lung Novartis Wins EU Approval for Cosentyx to Treat PMR Patients SonoClear Wins FDA Review for Brain Surgery Imaging Novartis Reports 20% Lower Death Risk With Kisqali Neurocrine Starts Phase 2 Alzheimer’s Study of NBI-567 Actinium Advances HER3 Radiotherapy for Prostate Cancer Amgen and AstraZeneca Report Positive Phase 3 TEZSPIRE Results in EoE Aardvark Therapeutics Announces FDA Lifts ARD-101 Clinical Hold IceCure Begins ProSense Breast Cancer Cryoablation Study Prilenia and Ferrer Secure EU Authorization for PRECISE-HD Trial Cognition Therapeutics Aligns with FDA on Phase 3 DLB Trial Synergy Spine Reports Real-World Results for Synergy Disc Oculis Reports New Biomarker Data Supporting Privosegtor in Optic Neuritis Insilico Medicine and Servier Reach AI Drug Discovery Milestone Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib Roivant Reports Positive Phase 3 Results for Brepocitinib in Uveitis Prenosis Deploys Sepsis AI Tool as ARDS Study Enrolls Sundance Biosciences Presents Positive Phase 1 Data for SUN-627 BioCryst Wins FDA Approval for ORLADEYO 150 mg Oral Pellets AstraZeneca and Oracle Partner to Advance AI in Clinical Research Sun Pharma’s UNLOXCYT Gains Preferred NCCN Status Opus Genetics Receives FDA IND Clearance for RDH12 Gene Therapy Bionyra Pharma Reports Positive Interim Phase 1 Results for BYN-002 Nanoscope Reports Durable Vision Restoration in Mice AbbVie Partners With McLaren F1 to Support Immunology Niagen Bioscience Makes Skincare a Core Tru Niagen Category